INTRODUCTION
Mouse retinal ganglion cells (RGC) 2 are born between E10 and E18 with the maximum rate of birth at E15. Cell death, on the other hand, occurs in two distinct phases. A first phase occurs before birth around E15.5 (20) . This corresponds to the peak of RGC neurogenesis. A second wave of apoptosis occurs during the early postnatal period, with a maximum at P2. This correlates with the time of elaboration and focusing of retinal ganglion cell projections in the target area of the superior colliculus (SC) (52) . In addition, RGCs are lost in a slow phase of age-related degeneration (47) , possibly due to oxidative stress (6) . Frade and Barde (20) reported that the early phase of cell death in mouse embryos is mediated by nerve growth factor (NGF) acting through its low-affinity receptor p75 (p75NTR), which is expressed at high levels in the developing ganglion cell layer and optic nerve. As the second phase of cell death correlates with the time of target innervation, it is generally thought that limiting amounts of neurotrophic factors in the target field control this phase of apoptosis. In support of this hypothesis, Ma et al. (29) have shown that BDNF injections into the SC of the intact hamster reduced the rate of RGC cell death during this phase. In addition, Cui and Harvey (13) demonstrated that neonatal RGCs, which normally undergo apoptosis if the target cells are removed, can be rescued by BDNF or neurotrophin 4 (NT-4) injections into the SC. Neurotrophins also in-fluence apoptosis of adult RGCs. Axotomy-induced apoptosis of RGCs can be delayed by applying BDNF in both adult mouse and rats (15, 30, 31) . BDNF is a survival factor for RGCs in vitro (32) , it is expressed in the retinorecipient layers of the SC in hamster and rat (29, 35) and is retrogradely transported to the retina (36) , suggesting that target-derived BDNF is a major source of the neurotrophin for RGCs. A major receptor for BDNF is the receptor tyrosine kinase TrkB. RGCs have been shown to express high levels of both fulllength and truncated forms of TrkB (39, 44) .
The neurotrophin receptor TrkB comes in two different isoforms, the full-length, kinase-containing isoform and two truncated isoforms, TrkB.T1 and TrkB.T2 (37) . Activation of TrkB tyrosine kinase stimulates cell survival pathways by triggering PI-3 kinase and Erk kinase cascades (42) . Signaling mechanisms of TrkB.T1 and TrkB.T2 are less certain. BDNF activation of TrkB.T1 or TrkB.T2 has been shown to increase the rate of acidic metabolite release from the cell, which is considered to be a common physiological consequence of many signaling pathways (3) . Truncated isoforms of TrkB also can inhibit the formation of dimers of kinase-containing isoforms of TrkB, thereby modulating BDNF signaling (19) . Yet the truncated receptors may not signal directly, but may instead regulate ligand availability by binding BDNF.
We have previously shown that trkB Ϫ/Ϫ animals, which have a life span of approximately 3 weeks, develop structurally normal but small eyes (39) . In these mice, the retinal layers develop normally although retinal cell migration and differentiation are delayed. Photoreceptor maturation is developmentally delayed, and synaptic signaling is severely impaired.
To test the hypothesis that TrkB kinase signaling is required for postnatal RGC survival, we took advantage of two lines of trkB mutant animals. The trkB Ϫ/Ϫ mice, which were previously used for the photoreceptor study, are complete null mutants, lacking both the full-length and the truncated isoforms of TrkB (39) . The trkB hypomorphic line also lacks the truncated forms of TrkB, but still expresses small amounts of the kinase-containing isoform (49, 50) . Contrary to our expectations, at P16 the lack of TrkB signaling in the trkB knockout mouse did not lead to an increase in cell death in the RGC layer, resulting in cell numbers indistinguishable from those of their wild-type littermates, but myelination in the optic nerve was reduced by 70%. Normal agerelated adult RGC degeneration, however, appears to be accelerated in the trkB hypomorphic animals. As a result, by P90, hypermorphic animals have lost approximately 20% of their RGCs in comparison to age-matched controls.
MATERIALS AND METHODS
Animals. Two trkB mutant lines were analyzed, the trkB knockout mouse (trkB Ϫ/Ϫ (39)) and a trkB hypomorphic line (trkB fbz/fbz (49, 50) ), as well as BDN-F lacZ heterozygous mice (5) . In the null mutant, expression of both the full-length and the truncated isoforms of TrkB is abolished by deletion of the first coding exon (exon S), which contains the start site and the signal peptide for TrkB and is shared by all TrkB isoforms (39) . This results in a complete absence of both the kinase and the nonkinase isoforms as confirmed by Northern and Western blotting (data not shown). TrkB Ϫ/Ϫ homozygous mutants die within 3 weeks of birth and reach only approximately 45% of the wildtype body weight (P16 WT, 11.4 Ϯ 1.28 g versus P16 trkB Ϫ/Ϫ , 4.86 Ϯ 1.22 g (39)). TrkB hypomorphic animals were created by inserting a rat trkB cDNA flanked by loxP sites and followed by an SV40 poly(A) sequence into the first coding exon. Homozygous trkB fbz/fbz animals do not express any truncated isoforms of TrkB. Although the expression of full-length TrkB is reduced by approximately 75% in comparison to their littermates (49), animals were found to survive for 6 months and longer. In the BDNF lacZ mice, the coding sequence of ␤-galactosidase was inserted into the coding exon of BDNF. As a result, cells that normally express the neurotrophin BDNF can be identified using the enzymatic activity of ␤-galactosidase or antibodies against the enzyme (5). Mice heterozygous for BDNF lacZ , with no known deficit in the visual system, were used in these studies.
Immunohistochemistry. Animals were sacrificed by cervical dislocation, after which eyes were enucleated and immersion fixed in Carnoy's fixative for 2 h. Eyes were then dehydrated and embedded in paraffin in transverse orientation. Seven-micrometer sections were cut and dried onto poly-L-lysine-coated glass slides, and sections were dewaxed and rehydrated for immunohistochemistry. Nonspecific binding was blocked in 3% bovine serum albumin and 10% normal goat serum in Tris-buffered saline, pH 7.4, containing 0.4% Triton X-100. Primary antibodies were applied in blocking solution overnight at room temperature (RT), followed by either fluorophore-coupled or biotinylated secondary antibodies for 4 h at RT. The enzymatic protocol was completed by incubation in ABC reagents (Vectastain) and using diaminobenzidine as substrate. For fluorescence double-labeling, primary and secondary antibodies were applied together. Slides were mounted in Fluoromount-G (Southern Biotechnology Assoc., Inc.) and analyzed by confocal microscopy. Digital images were pseudocolored and superimposed using Adobe PhotoShop software. Sections labeled with enzyme system techniques were dehydrated, embedded in Permount, and analyzed by light microscopy.
Antibodies used in this study include a polyclonal antibody raised to the extracellular domain of TrkB (24) that stains the majority of RGCs in mouse retina (39), a monoclonal antibody specific for ␤-galactosidase (Promega), a rabbit polyclonal antibody to Brn3A (25) , a transcription factor that stains the majority of mouse RGCs, and rabbit polyclonal antibodies (Swant, Switzerland) to two markers that, in the RGC layer, stain mainly displaced amacrine cells and very few retinal ganglion cells, parvalbumin and calbindin (22, 23) . FITC-coupled anti-rabbit and Texas red-coupled antimouse antibodies were purchased from Jackson Immuno-Research Laboratories, Inc. (West Grove, PA) and biotinylated anti-rabbit antibodies and the Vectastain kit from Vector Laboratories, Inc. (Burlingame, CA). Immunohistochemistry experiments were repeated on a minimum of five different eyes per genotype.
X-gal staining. Depending on the age of the animals, pups were deeply anesthetized either on ice or with avertin (30 mg/kg) and then were transcardially perfused with 2% paraformaldehyde (PFA) in phosphate-buffered saline (PBS, pH 7.4) for 5 min. Brains were removed immediately from the skull and the two hemispheres were separated, whereas the eyes were enucleated and the cornea pierced to allow fluid exchange. Both were washed extensively in PBS followed by substrate buffer (2 mmol/L MgCl 2 , 0.02% NP-40, 0.01% sodium deoxycholate in PBS, pH 7.3) to preserve enzymatic activity. Substrate was then added to the substrate buffer (final concentrations: 5 mmol/L ferrocyanide, 5 mmol/L ferricyanide, and 1 mg/ml X-gal in DMSO) and tissues were incubated for up to 12 h at 37°C to detect ␤-galactosidase activity. Tissues were postfixed in 4% PFA, equilibrated in 30% sucrose (in PBS), and embedded in OCT. Fourteen-micrometer frozen sections were cut using a cryostat. Images were taken using a standard bright-field microscopy.
Anterograde DiI tracing. Pups (P0 and P6, four animals per age and genotype) were deeply anesthetized on ice. The eyelids were carefully pried apart with a blunt pair of forceps. Small amounts of DiI (10% in dimethylformamide) were delivered into the RGC layer, using a micropipette (43) . The tip of the micropipette could be guided visually using the optics of the mouse eye. Four hours after dye delivery, animals were again deeply anesthetized on ice and transcardially perfused with 4% PFA (pH 7.4). The brain was mounted in 3.7% low-melting agar and sagittal sections (80 m) were cut using a Vibratome. DiI-labeled arbors were photographed using epifluorescence illumination and a standard automatic photographic attachment. Images were digitized and assembled using Adobe PhotoShop software. The retinal localization of the DiI injection in each experimental animal was verified in retinal flat mounts.
Semithin section. Animals were deeply anesthetized with CO 2 and perfused with fixative (4% glutaraldehyde, 2% PFA in PBS, pH 7.4). After enucleation, eyes were hemisected in dorsoventral orientation through the optic nerve and the superior and inferior oblique muscles, to ensure the same orientation in all eyes. Eyecups were embedded in Epon/Araldite following published procedures (39) . Semithin (1 m) sections were cut with a glass knife, stained with toluidine blue solution, and coverslipped using Permount medium. Cells in the RGC layer were counted in these sections, using a 60ϫ objective on a Nikon microscope. To be counted, a cell had to contain the nucleus and nucleolus. As each eye was cut in exactly the same orientation, accurate cell numbers, counting cells from the entire retinal circumference (ventral to dorsal), can be obtained. For statistical analysis, data were expressed as an average Ϯ standard deviation, and a two-tailed t test was used to determine significance levels.
Electron microscopy (EM). Tissues were collected as described for semithin sections. Optic nerves were postfixed in reduced osmium, stained with 2% uranyl acetate, dehydrated, and flat-embedded in Epon. Thin sections were cut, poststained with lead citrate and uranyl acid, and examined and photographed with an electron microscope. Electron micrographs were taken at 2500ϫ magnification systematically in an S shape, covering the entire optic nerve in 12 images. These images were digitized and analyzed using Adobe PhotoShop and NIH Image J software. All axon profiles in each digitized image were outlined and filled, using Adobe PhotoShop, producing 1 image for myelinated and 1 for unmyelinated axons. These binary images were exported into Image J to determine numbers of myelinated and unmyelinated axons as well as their axon surface area. Optic nerve areas were determined using digitized light-microscope images to allow for the calculation of the absolute number of RGC axon profiles in the optic nerve. The mean and standard deviation of profiles were calculated. We counted the total number of axons per image taken rather than using stereology, since total cell counting provides a more accurate count than even the most rigorous randomized sampling technique.
RESULTS

Expression Profiles of TrkB and BDNF in the Mouse Retinocollicular System
If target-derived BDNF, signaling through TrkB, plays a role in early postnatal RGC survival, TrkB must be expressed in early differentiating RGCs while BDNF is expressed in the SC at the time of target innervation (P2). To examine the distribution of BDNF, we used the BDNF lacZ mice. In the presence of the substrate X-gal, all the cells that would normally express BDNF are stained blue. At P2, BDNF was found to be expressed in the SC (Fig. 1A) . At P2, the layers of the mouse SC are poorly differentiated. The dorsal part of the SC will differentiate into two layers, the stratum opticum and stratum griseum superficiale, which receive visual inputs from retinal ganglion cells, whereas the ventral part of the SC will differentiate into layers that are reciprocally connected with brainstem areas and receive inputs from other neocortical areas (17) . BDNF expression was found to be moderate in the upper part of the SC and more abundant in the lower half. Interestingly, RGCs appear also to produce their own BDNF (Fig. 1B) , and there is additional expression in secretory cells overlying the ciliary body (Fig. 1B) . The pattern of BDNF expression in the retina appears to be almost identical from P0 to adulthood ((5); B. Rohrer personal observation).
Retinas from BDNF lacZ heterozygous mice were sectioned and immunostained for both ␤-galactosidase ( Fig. 2A) , as a monitor of endogenous BDNF, and TrkB (Fig. 2B) , using an antibody to the extracellular domain of TrkB. At all ages examined (P0 to adult), RGCs expressed both BDNF and its receptor. Figure 2 depicts an example of a P10 retina in which both ␤-galactosidase and TrkB are shown to be colocalized in the same RGCs. While anti-TrkB recognizes all isoforms of TrkB, data by Suzuki et al. (44) have shown that all RGCs express the truncated isoform of TrkB while approximately 70% express the kinase-containing isoform.
TrkB Ϫ/Ϫ RGCs Project Appropriately to the Superior Colliculus
To determine whether the RGCs of the trkB Ϫ/Ϫ animals project appropriately to and initiate branching in the retinorecipient layers of the dorsal SC, we DiIlabeled RGC projections at various ages. In mouse, axons arrive at the rostral SC at E15, project diffusely by P0, and initiate axonal arborization and synaptogenesis by P6 (18) . We DiI-labeled RGC projections at two time points: birth and P6.
Small amounts of DiI were injected into the RGC layer of anesthetized mouse pups. Four hours was found to be sufficient time for anterograde transport to occur at that age in vivo. Postnatal day 0 RGC projections were labeled with a small DiI injection close to the optic nerve head. As expected, we found that RGC axons from both wild-type and trkB Ϫ/Ϫ animals have entered the SC by that time (Fig. 3A) , and no obvious differences between the two genotypes were observed. The slightly stronger staining in the trkB Ϫ/Ϫ SC was due to a larger area of retina covered by the label. Postnatal day 6 projections were identified by DiI injections into the nasal or temporal retina to identify posterior and anterior projections, respectively. Here we show an example of P6 trkB Ϫ/Ϫ nasal retinal ganglion cell axons projecting to the posterior SC (Fig. 3C ) and initiating branching (arrows in Fig. 3D ). This pattern was not detectably different from projection patterns seen in WT littermates (data not shown). We did not investigate possible minor differences in branching pattern between the two genotypes, but the overall projection pattern were very similar.
Cell Survival in the RGC Layer in trkB
Ϫ/Ϫ Mice Cells in the RGC layer were examined in radial semithin plastic sections stained with toluidine blue (Fig. 4A) . As all of the sections were taken from the central retina, and numbers of cells in the RGC layer are very constant between animals, a loss of RGCs should be readily detectable. Numbers of cells in the retinal ganglion cell layer were counted in wild-type (n ϭ 11), heterozygous (n ϭ 5), and homozygous (n ϭ 6) littermates between P10 and P16. As the period of cell death is over by P6 (52) and cells are not generated in the RGC layer after E18, we pooled the numbers for each genotype. Interestingly, no significant difference in cell numbers could be detected between the three groups. As shown in Fig. 5A , all three had about 330 retinal ganglion cells per circumference (WT, 339.5 Ϯ 6.3; Het, 325.6 Ϯ 20.9; KO, 323.5 Ϯ 13.2; ns). In addition, no increase in pyknotic profiles in the RGC layers of any of the mutant retinas was detected (data not shown).
RGCs make up only about 40% of all the cells in the RGC layer. The other 60% are displaced amacrine cells (26) . To examine the possibility of cellular compensation in the RGC layer, we examined P16 trkB Ϫ/Ϫ retina with antibodies specific for RGCs (Fig. 4B ) and displaced amacrine cells (Figs. 4C and 4D ). Brn3A is a transcription factor that labels the majority of RGC nuclei (25) ; while in the RGC layer, calbindin and parvalbumin label predominantly displaced amacrine cells and a few RGCs (23) . With each of the antibodies, we could not detect a significant reduction in number of stained cells in the RGC layer of the trkB Ϫ/Ϫ retinas, consistent with our cell counts.
Number of RGC Axons Is Not Reduced by Loss of TrkB
Although cell counts and immunohistochemical analyses did not reveal any apparent differences in numbers of immunopositive cells in the RGC layer, structural changes could have gone unnoticed. We therefore examined the optic nerves by electron microscopy from P14 WT and trkB Ϫ/Ϫ animals (three animals per genotype). Numbers of myelinated and unmyelinated axons were compared and axon areas measured (Fig. 5B) .
Counts of axons in the optic nerve (Fig. 5C ) confirmed that there is no significant difference in the total number of retinal ganglion cells between the wildtype and the trkB Ϫ/Ϫ animals (66,100 Ϯ 11,400 versus 70,800 Ϯ 16,800, ns). These numbers are comparable with data collected by Williams et al. (48) , who reported numbers between 50,800 Ϯ 1100 and 75,800 Ϯ 2200, depending on the mouse strain analyzed. There is, however, a difference in the number and percentage of myelinated axons (18, 5D ). Similar results were obtained by Cellerino et al. (8) , in the BDNF knockout mouse where they reported a 50% reduction in number of myelinated RGC and CNS axons without an effect on myelination of peripheral nerves. These authors, therefore, argued that the malnutrition or reduced body weight could not explain the hypomyelination. We have not examined myelination in CNS versus PNS neurons in the trkB Ϫ/Ϫ mouse, but expect that it is similar to that found in the BDNF Ϫ/Ϫ mutant. 
TrkB Activation Appears to Slow Adult RGC Degeneration
Results presented above demonstrate that TrkB expression does not regulate the survival of immature RGCs at the time of target innervation. However, the life span of trkB Ϫ/Ϫ animals is limited to a few weeks. To determine whether TrkB modulates the later loss of RGCs observed in aging adult animals, we used a second line of trkB transgenic animals in which a trkB cDNA followed by an SV40 poly(A) sequence was inserted into the first coding exon immediately following the ATG. Animals homozygous for this allele do not express truncated isoforms of TrkB and express only about 25% of the normal amount of the kinase-containing isoform of TrkB. The pattern of TrkB expression appears identical to that of TrkB in wild-type animals, which is not surprising since only a few hundred bases of exon DNA were deleted from the genome during construction of this allele (49) .
The rodent retina is physiologically mature by P50 (21) , and adult RGCs appear to decline by approximately 30% by 27 months of age (47) . At 3 months of age, numbers of RGC in the wild-type retina were not significantly lower than at P14 (compare Fig. 5A to Fig.  6A ). In animals expressing low amounts of trkB, the number of cells in the RGC layer was reduced by 20% at 3 months of age (Fig. 6A) . The RGC layer of wildtype animals contained 323.3 Ϯ 16.2 cells per circumference (n ϭ 6), in comparison to 267.1 Ϯ 24.1 cells per circumference in the RGC layer of trkB fbz/fbz (n ϭ 6; P Ͻ 0.001). Observations consistent with these counts were obtained by electron microscope analysis of sections of P90 optic nerves (Fig. 6B) . To confirm a 20% reduction in absolute numbers using electron microscopy is virtually impossible due to the nature of statistical sampling, unless very large numbers of samples are counted. Thus, we confirmed only the overall trend that the number of axons is reduced by approximately 16% (78,495 Ϯ 15,212 versus 66,069 Ϯ 12,582; P Ͻ 0.3, (5167 Ϯ 2089 versus 4545 Ϯ 3080, P Ͻ 0.8). The average area of myelinated (0.57 Ϯ 0.081 versus 0.51 Ϯ 0.089 m 2 , ns) and unmyelinated axons (0.26 Ϯ 0.028 versus 0.28 Ϯ 0.023 m 2 , ns) was not affected by the reduction in TrkB expression (Fig. 6D) . Even though this dataset does not reach statistical significance, these EM results appear consistent with the results obtained by light microscopy.
DISCUSSION
Although RGCs express a variety of growth factor receptors, experiments have suggested that their postnatal survival is regulated by a ligand of TrkB, BDNF, NT-4, or possibly NT-3 (15, 29, 31, 32) . Using X-gal staining and immunohistochemistry, we demonstrated that TrkB is expressed in RGCs and BDNF is expressed in the target areas in the SC as well as in the RGCs. Expression in RGCs and SC potentially allows for both paracrine and autocrine mechanisms of TrkB activation. RGCs of trkB Ϫ/Ϫ animals were found to project appropriately to the SC. Contrary to our expectations, increased apoptosis of RGCs was not observed during the target-dependent phase of RGC survival. The absence of TrkB, however, did result in a significant reduction in the extent of axonal myelination. Since these animals are small, and malnutrition has been reported to affect myelination in early postnatal animals (1), it is not certain that this effect is direct. A reduction of 75% in TrkB kinase in the hypomorphic animals, on the other hand, leads to a small loss of approximately 20% of RGCs at 3 months of age without affecting myelination, suggesting that TrkB-mediated signaling may help prevent degeneration of RGCs in the mature retina.
RGCs Do Not Require TrkB Activation for Survival During Target Innervation
It has been shown that the number of RGCs in the BDNF Ϫ/Ϫ mouse is not reduced (8) . Although these results suggest that TrkB activation is not required for RGC survival, two other ligands for TrkB, NT-3 and NT-4, are also present in the mouse visual system. NT-3 appears to be present in some cells in the RGC layer (5) and NT-4 has been demonstrated in the mouse retina by reverse transcriptase-PCR (B. Rohrer, unpublished observation). Interestingly, in mice that lack all isoforms of the receptor TrkB, RGCs project to the SC and branch in retinorecipient layers (Fig. 3) , and their survival is unaffected at least until P16 (Figs.  4 and 5) , the oldest time point studied due to the limited survival-time of the trkB Ϫ/Ϫ animals. These findings are interesting with respect to pathfinding and axonal branching, as well as RGC survival and function. TrkB activation was thought to promote both axonal branching (9, 11) and survival (29) . We did not investigate other aspects of RGC physiology. This has been done in the BDNF Ϫ/Ϫ mice, and it is expected that results in trkB Ϫ/Ϫ animals will be similar (40) . The experiments presented here are consistent with the results obtained in the BDNF Ϫ/Ϫ mouse, suggesting that immature RGCs do not require TrkB activation by BDNF or its other ligands for their survival. They do not, however, eliminate the possibility that TrkB and BDNF promote RGC survival, but are not essential because of other compensatory survival mechanisms.
TrkB and Age-Related Retinal Ganglion Cell Loss
Age-related structural changes in the rodent retina include a gradual loss of RGCs (7, 38, 47) , which is consistent with changes described in the human optic nerve (16) . One possible cause for the gradual cell loss is oxidative stress. As the retina requires large amounts of oxygen and is exposed to visible light, it produces reactive oxygen intermediates such as free radicals, hydrogen peroxide, and singlet oxygen as the by-products of oxygen metabolism. The young retina appears to create its own protective environment in response to light by increasing retinal levels of antioxidants and through expression of bFGF and CNTF (28) . Additional neuroprotective mechanisms include the retrograde transport of BDNF and NGF (45) .
Unfortunately, stress response genes and antioxidants appear to be downregulated in the aging retina and brain (4, 6, 10) . In addition, less BDNF and TrkB are present in the aging compared to the young brain (12, 33) . Consequently, oxidative stress could cause cellular damage and possibly trigger diseases such as age-related RGC degeneration. Our observation on the elevated loss of RGC in an animal expressing low levels of TrkB receptor (trkB fbz/fbz ) suggest that TrkB activation may help maintain cellular antioxidant defenses in the mature retina. Alternatively, the developmental cell loss of RGCs that occur during target innervation may never stop, but rather progress at a slow rate.
Potential Mechanisms of TrkB Action
Which BDNF-responsive neurotrophin receptors are expressed by the RGCs? Here we have demonstrated that RGCs in the mouse retina express TrkB at the time of target innervation (Fig. 2B ). Although we were not able to distinguish between the expression patterns of the kinase-containing and the truncated isoforms of TrkB, because the antibody used in this study was raised against the extracellular domain of TrkB, recent data using mRNA probes specific for either the truncated isoforms or the full-length form of trkB have demonstrated that all RGCs express the truncated form of trkB, and approximately 70% of all RGCs also express the full-length form of trkB (44) . A similar-sized subset also expresses p75NTR, although no attempt was made to study colocalization between p75NTR and the two TrkB isoforms. Thus all three receptor isoforms are present in RGCs to mediate potentially the neurotrophin effect.
A comparison of different neurotrophin receptor knockout mice could possibly explain the survival effects we have seen in our experiments. During early postnatal development, RGCs in the trkB Ϫ/Ϫ animals that lack both TrkB.T1/T2 and TrkB kinase do not die at a higher rate than their wild-type counterparts (Figs. 4 and 5) , but long-term maintenance of adult RGCs appears to be impaired (Fig. 6) . On the other hand, Pollock and co-workers (34) have reported that in a different trkB mutant mouse, in which only the kinase exon has been deleted (27) , a sevenfold increase in RGC pyknosis was observed at P6. Unfortunately, no data on RGC numbers are available on the TrkB.T1-overexpressing mouse (41) . Finally, postnatal survival of RGCs from p75NTR Ϫ/Ϫ animals has not been investigated. The comparison of these sets of results allows for a couple of interpretations: (1) Activation of fulllength TrkB promotes long-term survival of RGCs and is thus responsible for maintaining the adult neuronal phenotype or (2) an imbalance of full-length TrkB and TrkB.T1/T2 in favor of the truncated isoform may be detrimental during the target-dependent phase of RGC development. TrkB.T1/T2 activation by excess neurotrophin in the absence of full-length TrkB may activate a cell death pathway in a way similar to that in human retinoblastoma tumor cells, in which a favorable tumor prognosis (i.e., the activation of the cell death pathway) depends on increased levels of TrkB.T1 (2) . Alternatively, sequestration of BDNF, NT-4, or NT-3 by TrkB.T1/T2 may inhibit an alternate, neurotrophindependent survival pathway. Taken together, RGCs may survive the lack of full-length TrkB stimulation if truncated isoforms of TrkB are not present, by relying on other endogenous survival factors such as CNTF (14, 46) and basic fibroblast growth factor (53) or neurotrophins acting through p75NTR (51) .
CONCLUSION
Studies of naturally occurring cell death have attracted much attention as molecules involved in these early processes could also play a role in degenerative processes or aging. We were interested in investigating further the roles in RGC survival of BDNF, NT-4, and NT-3 acting through their receptor TrkB. Although both BDNF and its receptor are expressed during both the period of naturally occurring cell death and beyond, we were unable to establish a survival role for neurotrophin signaling through TrkB, but found possible evidence for their involvement in early aging. As RGCs express other receptors for growth factors that can be provided by both target areas and the retina itself, we will further investigate the role of survival factors in additional mouse mutants. It will be interesting to study RGC development in double mutants or conditional mutants to further understand the dependence of RGCs on survival factors. This is particularly important in light of the potential use of growth factors as therapeutic agents for macular degeneration.
